The level of macrophage migration inhibitory factor is negatively correlated with the efficacy of PD-1 blockade immunotherapy combined with chemotherapy as a neoadjuvant therapy for esophageal squamous cell carcinoma

PURPOSE: This study aimed to screen biomarkers to predict the efficacy of programmed cell death 1 (PD-1) blockade immunotherapy combined with chemotherapy as neoadjuvant therapy for esophageal squamous cell carcinoma (ESCC). METHODS: In the first stage of the study, the baseline concentrations of 40...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Liangliang, Gao, Yiming, Xie, Shengzhi, Ye, Wan, Uemura, Yasushi, Zhang, Rong, Yu, Yanju, Li, Jinfeng, Chen, Man, Wu, Qiyan, Cui, Pengfei, Liu, Hongyu, Mu, Shuai, Li, Yilan, Wang, Lingxiong, Liu, Chunxi, Li, Jiahui, Zhang, Lijun, Jiao, Shunchang, Zhang, Guoqing, Liu, Tianyi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Neoplasia Press 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10492201/
https://www.ncbi.nlm.nih.gov/pubmed/37678132
http://dx.doi.org/10.1016/j.tranon.2023.101775

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10492201/
https://www.ncbi.nlm.nih.gov/pubmed/37678132
http://dx.doi.org/10.1016/j.tranon.2023.101775

Ejemplares similares